KAT5-mediated HSPA1A lactylation drives immunotherapy resistance by inhibiting STAT1 degradation in esophageal squamous cell carcinoma.
- DOI
- 10.1038/s41388-026-03993-5
- Published
- 2026 Sep 24
- Container
- Oncogene
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41388-026-03993-5,
title = {KAT5-mediated HSPA1A lactylation drives immunotherapy resistance by inhibiting STAT1 degradation in esophageal squamous cell carcinoma.},
author = {Wang Z and Li X and Luo P and Li S and Xu Y and Li W and Liu Q and Chen Y and Sun X},
year = {2026},
journal = {Oncogene},
doi = {10.1038/s41388-026-03993-5},
url = {https://doi.org/10.1038/s41388-026-03993-5}
}RIS
TY - JOUR TI - KAT5-mediated HSPA1A lactylation drives immunotherapy resistance by inhibiting STAT1 degradation in esophageal squamous cell carcinoma. AU - Wang Z AU - Li X AU - Luo P AU - Li S AU - Xu Y AU - Li W AU - Liu Q AU - Chen Y AU - Sun X PY - 2026 JO - Oncogene DO - 10.1038/s41388-026-03993-5 UR - https://doi.org/10.1038/s41388-026-03993-5 ER -
APA
Z, W., X, L., P, L., S, L., Y, X., W, L., Q, L., Y, C., & X, S. (2026). KAT5-mediated HSPA1A lactylation drives immunotherapy resistance by inhibiting STAT1 degradation in esophageal squamous cell carcinoma.. Oncogene. https://doi.org/10.1038/s41388-026-03993-5
Source records
- pubmed · retrieved 2026-09-25T14:22:04.765Z